Interplay of histidine residues of the Alzheimer's disease Aβ peptide governs its Zn-induced oligomerization

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Istrate, Andrey N ^a   Kozin, Sergey A ^a   Zhokhov, Sergey S ^b   Mantsyzov, Alexey B ^b   Kechko, Olga I ^a   Pastore, Annalisa ^c   Makarov, Alexander A ^a   Polshakov, Vladimir I ^b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b LOMONOSOV MOSCOW STATE UNIVERSITY   (Russian Federation)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-16); HISTIDINE; PEPTIDE FRAGMENT; PROTEIN AGGREGATE; PROTEIN BINDING; SOLUTION AND SOLUBILITY; ZINC;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITE; CHEMISTRY; HUMAN; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; SOLUTION AND SOLUBILITY; SYNTHESIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PEPTIDES; BINDING SITES; HISTIDINE; HUMANS; MOLECULAR DYNAMICS SIMULATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; PROTEIN BINDING; PROTEIN DOMAINS; PROTEIN MULTIMERIZATION; SOLUTIONS; ZINC;

EID: 84959132196     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21734     Document Type: Article

References (80)

1. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356, doi: 10.1126/science.1072994 (2002).
2. Musiek, E. S. & Holtzman, D. M. Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat Neurosci 18, 800-806, doi: 10.1038/nn.4018 (2015).
3. Meyer-Luehmann, M. et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781-1784, doi: 10.1126/science.1131864 (2006).
4. Ayton, S., Lei, P. & Bush, A. Biometals and Their Therapeutic Implications in Alzheimer's Disease. Neurotherapeutics 12, 109-120, doi: 10.1007/s13311-014-0312-z (2015).
5. Ballard, C. et al. Alzheimer's disease. Lancet 377, 1019-1031, doi: 10.1016/S0140-6736(10)61349-9 (2011).
6. Hamley, I. W. The Amyloid Beta Peptide: A Chemist's Perspective. Role in Alzheimer's and Fibrillization. Chem Rev 112, 5147-5192, doi: 10.1021/cr3000994 (2012).
7. Bush, A. I. The Metal Theory of Alzheimer's Disease. J Alzheimer's Disease 33, S277-S281, doi: 10.3233/jad-2012-129011 (2013).
8. Deshpande, A., Kawai, H., Metherate, R., Glabe, C. G. & Busciglio, J. A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. The Journal of neuroscience : the official journal of the Society for Neuroscience 29, 4004-4015, doi: 10.1523/jneurosci.5980-08.2009 (2009).
9. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery, W. R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52, doi: S0022-510X(98)00092-6 [pii] (1998).
10. Suh, S. W. et al. Histochemically-reactive zinc in amyloid plaques, angiopathy and degenerating neurons of Alzheimer's diseased brains. Brain Res 852, 274-278, doi: 10.1016/S0006-8993(99)02096-X (2000).
11. Miller, Y., Ma, B. & Nussinov, R. Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states. Proc. Natl. Acad. Sci. USA 107, 9490-9495, doi: 10.1073/pnas.0913114107 (2010).
12. Iannuzzi, C. et al. The role of zinc in the stability of the marginally stable IscU scaffold protein. Prot Sci 23, 1208-1219, doi: 10.1002/pro.2501 (2014).
13. Lim, K. H., Kim, Y. K. & Chang, Y.-T. Investigations of the Molecular Mechanism of Metal-Induced Aβ (1- 40) Amyloidogenesis. Biochemistry 46, 13523-13532, doi: 10.1021/bi701112z (2007).
14. Nasica-Labouze, J. et al. Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies. Chem Rev 115, 3518-3563, doi: 10.1021/cr500638n (2015).
15. Faller, P. & Hureau, C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans, 1080-1094, doi: 10.1039/b813398k (2009).
16. Kozin, S. A., Zirah, S., Rebuffat, S., Hoa, G. H. & Debey, P. Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex. Biochem Biophys Res Commun 285, 959-964, doi: 10.1006/bbrc.2001.5284 (2001).
17. Zirah, S. et al. Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging. J Biol Chem 281, 2151-2161, doi: 10.1074/jbc.M504454200 (2006).
18. Portelius, E. et al. A novel pathway for amyloid precursor protein processing. Neurobiol Aging 32, 1090-1098, doi: 10.1016/j.neurobiolaging.2009.06.002 (2011).
19. Colvin, M. T. et al. High Resolution Structural Characterization of Abeta42 Amyloid Fibrils by Magic Angle Spinning NMR. J Am Chem Soc 137, 7509-7518, doi: 10.1021/jacs.5b03997 (2015).
20. Luhrs, T. et al. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A 102, 17342-17347, doi: 10.1073/pnas.0506723102 (2005).
21. Talmard, C., Guilloreau, L., Coppel, Y., Mazarguil, H. & Faller, P. Amyloid-beta peptide forms monomeric complexes with Cu(II) and Zn(II) prior to aggregation. Chembiochem 8, 163-165, doi: 10.1002/cbic.200600319 (2007).
22. Barrow, C. J. & Zagorski, M. G. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182, doi: 10.1126/science.1853202 (1991).
23. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P. & Craik, D. J. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 37, 11064-11077, doi: 10.1021/bi972979f (1998).
24. Crescenzi, O. et al. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur J Biochem 269, 5642-5648, doi: 10.1046/j.1432-1033.2002.03271.x (2002).
25. Danielsson, J., Andersson, A., Jarvet, J. & Graslund, A. 15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length. Magnetic resonance in chemistry: MRC 44 Spec No, S114-121, doi: 10.1002/mrc.1814 (2006).
26. Eker, F., Griebenow, K. & Schweitzer-Stenner, R. Aβ (1-28) Fragment of the Amyloid Peptide Predominantly Adopts a Polyproline II Conformation in an Acidic Solution† . Biochemistry 43, 6893-6898, doi: 10.1021/bi049542+ (2004).
27. Jarvet, J. et al. A left-handed 3(1) helical conformation in the Alzheimer Abeta(12-28) peptide. FEBS Lett 555, 371-374, doi: 10.1016/S0014-5793(03)01293-6 (2003).
28. Petkova, A. T. et al. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99, 16742-16747, doi: 10.1073/pnas.262663499 (2002).
29. Shao, H., Jao, S., Ma, K. & Zagorski, M. G. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. J Mol Biol 285, 755-773, doi: 10.1006/jmbi.1998.2348 (1999).
30. Sticht, H. et al. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur J Biochem 233, 293-298, doi: 10.1111/j.1432-1033.1995.293-1.x (1995).
31. Nisbet, R. M. et al. Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide. Prot: Struct Funct Bioinform 81, 1748-1758, doi: 10.1002/prot.24312 (2013).
32. Cavalli, S., Albericio, F. & Kros, A. Amphiphilic peptides and their cross-disciplinary role as building blocks for nanoscience. Chemical Society reviews 39, 241-263, doi: 10.1039/b906701a (2010).
33. Furlan, S., Hureau, C., Faller, P. & La Penna, G. Modeling the Cu+ binding in the 1-16 region of the amyloid-beta peptide involved in Alzheimer's disease. J Phys Chem B 114, 15119-15133, doi: 10.1021/jp102928h (2010).
34. Tsvetkov, P. O. et al. Minimal Zn(2+ ) binding site of amyloid-beta. Biophys J 99, L84-86, doi: 10.1016/j.bpj.2010.09.015 (2010).
35. Mezentsev, Y. V. et al. Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease? J Biomol Struct Dyn, 1-34, doi: 10.1080/07391102.2015.1113890 (2015).
36. Kozin, S. A. et al. The English (H6R) familial Alzheimer's disease mutation facilitates zinc-induced dimerization of the amyloid-beta metal-binding domain. Metallomics 7, 422-425, doi: 10.1039/c4mt00259h (2015).
37. Kozin, S. A. et al. Zinc-induced dimerization of the amyloid-beta metal-binding domain 1-16 is mediated by residues 11-14. Mol Biosyst 7, 1053-1055, doi: 10.1039/c0mb00334d (2011).
38. Kulikova, A. A. et al. Phosphorylation of Ser8 promotes zinc-induced dimerization of the amyloid-beta metal-binding domain. Mol Biosyst 10, 2590-2596, doi: 10.1039/c4mb00332b (2014).
39. Masters, C. L. & Selkoe, D. J. Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor perspectives in medicine 2, a006262, doi: 10.1101/cshperspect.a006262 (2012).
40. Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45-51, doi: 10.1038/nature12481 (2013).
41. Stöhr, J. et al. Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc Natl Acad Sci U S A 109, 11025-11030, doi: 10.1073/pnas.1206555109 (2012).
42. Kummer, M. P. & Heneka, M. T. Truncated and modified amyloid-beta species. Alzheimer's research & therapy 6, 28, doi: 10.1186/alzrt258 (2014).
43. Tsvetkov, P. O. et al. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide. Chembiochem 9, 1564-1567, doi: 10.1002/cbic.200700784 (2008).
44. Kozin, S. A. et al. Peripherally applied synthetic peptide isoAsp7-Abeta(1-42) triggers cerebral beta-amyloidosis. Neurotoxicity research 24, 370-376, doi: 10.1007/s12640-013-9399-y (2013).
45. Faller, P., Hureau, C. & La Penna, G. Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-β to General Principles. Acc Chem Res 47, 2252-2259, doi: 10.1021/ar400293h (2014).
46. Curtain, C. C. et al. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 276, 20466-20473, doi: 10.1074/jbc.M100175200 (2001).
47. Istrate, A. N. et al. NMR Solution Structure of Rat A beta(1-16): Toward Understanding the Mechanism of Rats' Resistance to Alzheimer's Disease. Biophys J 102, 136-143, doi: DOI 10.1016/j.bpj.2011.11.4006 (2012).
48. Syme, C. D. & Viles, J. H. Solution1 H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease. Biochim Biophys Acta 1764, 246-256, doi: 10.1016/j.bbapap.2005.09.012 (2006).
49. Post, C. B. & Exchange-transferred NOE spectroscopy and bound ligand structure determination. Curr Opin Struct Biol 13, 581-588, doi: 10.1016/j.sbi.2003.09.012 (2003).
50. Dudev, T. & Lim, C. Principles governing Mg, Ca and Zn binding and selectivity in proteins. Chemical Reviews 103, 773-787, doi: 10.1021/cr020467n (2003).
51. Istrate, A. N., Mantsyzov, A. B., Kozin, S. A. & Polshakov, V. I. Optimization of the methods for small peptide solution structure determination by NMR spectroscopy. Mol. Biol. 44, 958-967, doi: 10.1134/S0026893310060130 (2010).
52. Fielding, L. Determination of association constants (Ka ) from solution NMR data. Tetrahedron 56, 6151-6170, doi: 10.1016/S0040-4020(00)00492-0 (2000).
53. Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. N Engl J Med 362, 329-344, doi: 10.1056/NEJMra0909142 (2010).
54. Wälti, M. A., Orts, J., Vogeli, B., Campioni, S. & Riek, R. Solution NMR studies of recombinant Abeta(1-42): from the presence of a micellar entity to residual beta-sheet structure in the soluble species. Chembiochem 16, 659-669, doi: 10.1002/cbic.201402595 (2015).
55. Bertini, I., Gonnelli, L., Luchinat, C., Mao, J. & Nesi, A. A new structural model of Abeta40 fibrils. J Am Chem Soc 133, 16013-16022, doi: 10.1021/ja2035859 (2011).
56. Potapov, A., Yau, W. M., Ghirlando, R., Thurber, K. R. & Tycko, R. Successive Stages of Amyloid-beta Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization. J Am Chem Soc 137, 8294-8307, doi: 10.1021/jacs.5b04843 (2015).
57. Dulin, F. et al. P3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomers. FEBS Lett 582, 1865-1870, doi: 10.1016/j.febslet.2008.05.002 (2008).
58. Walsh, D. M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539, doi: 10.1038/416535a (2002).
59. Di Fede, G. et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323, 1473-1477, doi: 10.1126/science.1168979 (2009).
60. Ono, K., Condron, M. M. & Teplow, D. B. Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid beta-Protein Assembly and Toxicity. J Biol Chem 285, 23184-23195, doi: 10.1074/jbc.M109.086496 (2010).
61. Gardberg, A. S. et al. Molecular basis for passive immunotherapy of Alzheimer's disease. Proc Natl Acad Sci U S A 104, 15659-15664, doi: 10.1073/pnas.0705888104 (2007).
62. Miller, Y., Ma, B. & Nussinov, R. Metal binding sites in amyloid oligomers: Complexes and mechanisms. Coord Chem Rev 256, 2245-2252, doi: 10.1016/j.ccr.2011.12.022 (2012).
63. Talmard, C., Leuma Yona, R. & Faller, P. Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28). J Biol Inorg Chem 14, 449-455, doi: 10.1007/s00775-008-0461-9 (2009).
64. Alies, B., Solari, P. L., Hureau, C. & Faller, P. Dynamics of Zn(II) binding as a key feature in the formation of amyloid fibrils by Abeta11-28. Inorg Chem 51, 701-708, doi: 10.1021/ic202247m (2012).
65. Barnham, K. J. et al. Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Proc Natl Acad Sci USA 105, 6813-6818, doi: 10.1073/pnas.0800712105 (2008).
66. Toropygin, I. Y. et al. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 22, 231-239, doi: 10.1002/rcm.3357 (2008).
67. Tsvetkov, P. O. et al. Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral beta-Amyloidosis in A beta PP/PS1 Transgenic Mice. Journal of Alzheimers Disease 46, 849-853, doi: 10.3233/Jad-150031 (2015).
68. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293, doi: 10.1007/BF00197809 (1995).
69. Goddard, T. D. & Kneller, D. G., Sparky - NMR Assignment and Integration Software (2008) Date of access: 07/01/2016, http://www.cgl.ucsf.edu/home/sparky.
70. Van Der Spoel, D. et al. GROMACS: fast, flexible and free. J. Comput. Chem. 26, 1701-1718, doi: 10.1002/jcc.20291 (2005).
71. Hornak, V. et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65, 712-725, doi: 10.1002/prot.21123 (2006).
72. Biswas, P. K. A regularized and renormalized electrostatic coupling Hamiltonian for hybrid quantum-mechanical/molecular-mechanical calculations. J. Chem. Phys. 123, 164114, doi: 10.1063/1.2064907 (2005).
73. Laio, A. A Hamiltonian electrostatic coupling scheme for hybrid Car-Parrinello molecular dynamics simulations. J. Chem. Phys. 116, 6941, doi: 10.1063/1.1462041 (2002).
74. Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R. & Thornton, J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486, doi: 10.1007/BF00228148 (1996).
75. Pettersen, E. F. et al. UCSF chimera - A visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612, doi: 10.1002/jcc.20084 (2004).
76. Jakalian, A., Bush, B. L., Jack, D. B. & Bayly, C. I. Fast, efficient generation of high-quality atomic Charges. AM1-BCC model: I. Method. J Comput Chem 21, 132-146, doi: 10.1002/(Sici)1096-987x(20000130)21:2〈132::Aid-Jcc5〉3.3.Co;2-G (2000).
77. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950-1958, doi: 10.1002/prot.22711 (2010).
78. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. 79, 926-935, doi: 10.1063/1.445869 (1983).
79. Darden, T., York, D. & Pedersen, L. Particle Mesh Ewald - an N.Log(N) Method for Ewald Sums in Large Systems. J. Chem. Phys. 98, 10089-10092, doi: 10.1063/1.464397 (1993).
80. Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463-1472, doi: 10.1002/(sici)1096-987x(199709)18:12〈1463::aid-jcc4〉3.0.co;2-h (1997).